More recently, MS preclinical and clinical studies have revealed that miR-142-3p is part of a detrimental regulatory axis with the pro-inflammatory cytokine IL-1β, which contributes to excitotoxic synaptic overstimulation with serious consequences for disease prognosis and the efficacy of disease-modifying treatments [5,6]. This evidence concerns the gene IL1B and myeloid sarcoma.